Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.
| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q4 2025 | Exited | −94K | – | −100.0% | 0 | Feb 17, 2026 |
| Q3 2025 | Reduced | −86K | – | −47.7% | 94K | Nov 14, 2025 |
| Q2 2025 | Reduced | −165K | – | −47.8% | 180K | Aug 14, 2025 |
| Q1 2025 | Added | +73K | – | +26.7% | 346K | May 15, 2025 |
| Q4 2024 | Reduced | −75K | – | −21.5% | 273K | Feb 14, 2025 |
| Q3 2024 | Added | +297K | – | +582.5% | 347K | Nov 14, 2024 |
| Q2 2024 | Added | +18K | – | +55.0% | 51K | Aug 14, 2024 |
| Q1 2024 | Reduced | −92K | – | −73.7% | 33K | May 15, 2024 |
| Q4 2023 | Added | +90K | – | +258.9% | 125K | Feb 14, 2024 |
| Q3 2023 | Added | +22K | – | +175.7% | 35K | Nov 14, 2023 |
| Q2 2023 | Reduced | −47K | – | −78.7% | 13K | Aug 14, 2023 |
| Q1 2023 | Reduced | −52K | – | −46.6% | 59K | May 15, 2023 |
| Q4 2022 | Added | +47K | – | +72.9% | 111K | Feb 14, 2023 |
| Q3 2022 | Added | +10K | – | +19.6% | 64K | Nov 14, 2022 |
| Q2 2022 | Added | +23K | – | +74.8% | 54K | Aug 15, 2022 |
| Q1 2022 | New | +31K | – | – | 31K | May 16, 2022 |
| Q2 2021 | Reduced | −15K | – | −37.0% | 25K | Aug 16, 2021 |
| Q1 2021 | First covered | – | – | – | 40K | May 21, 2021 |
Not currently. Ken Griffin fully exited CHCT in Q4 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Ken Griffin held CHCT since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Yes. Ken Griffin reduced and then fully exited CHCT by Q4 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
None as of the latest filing: Ken Griffin has exited CHCT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Ken Griffin began building the CHCT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
